MedTrace Logo

Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity

NCT04768439 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-09-14

No results posted yet for this study

Summary

In this study the effects of low and high doses of prophylactic vitamin D on biochemical and radiological manifestations of osetopenia of prematurity will be tested.

Conditions

  • Osteopenia of Prematurity

Interventions

DRUG

Low Dose Vitamin D

Patients will receive a 200 IU/d vitamin D since they tolerate full enteral nutrition.

DRUG

High Dose Vitamin D

Patients will receive 1600 IU/d vitamin D since they tolerate full enteral nutrition.

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Marwa M Farrag, PhD · Faculty of Medicine, Alexandria University, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2021-04-20
Completion
2021-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768439 on ClinicalTrials.gov